• Needham & Company LLC Reaffirms Buy Rating for Day One Biopharmaceuticals (NASDAQ:DAWN)

    Source: Buzz FX / 26 Feb 2025 08:26:19   America/New_York


    Needham & Company LLC Reaffirms Buy Rating for Day One Biopharmaceuticals (NASDAQ:DAWN) Written by MarketBeat February 26, 2025 Share Link copied to clipboard. Day One Biopharmaceuticals ( NASDAQ:DAWN - Get Free Report ) 's stock had its "b
    Read more...
Share on,